OTR-AC (MK-29, Ostarine-O-Acetate )

Description

Product Overview:

This product is a liquid formulation containing 50 ml of solution at a concentration of 10 mg/ml, providing a total of 50 x 10 mg (or 500 mg per vial).

Chemical Information:

• Molecular Weight: 453.498 g/mol
• Molecular Formula: C21H18F3N03S2

Solubility:
The product is soluble in polyglycols, making it suitable for various application methods where such solvents are applicable.

Purity:
The substance boasts a high purity of >99%, ensuring high-quality performance in its intended applications.

Storage Conditions:
To maintain the product’s efficacy, it should be stored at a temperature of 20℃ and can remain stable for a period of up to 2 years under proper storage conditions.

Pharmacokinetics:
– Half-Life: The half-life of the compound is approximately 24 hours, indicating how long it remains active in the system before being metabolized or eliminated.

Regulatory Information:
– CAS Number: 317318-70-0

Note: The information provided is based on data available up to October 2023 and has been last modified on February 1st, 2024. Always refer to current guidelines and safety data sheets when handling chemicals.

Senza un contesto specifico, è difficile associare questi dati a un integratore alimentare specifico. Tuttavia, dal peso molecolare e dalla formula molecolare, posso ipotizzare che si riferiscono a GW501516, noto anche come Cardarine o Endurobol.

Qui ci sono alcune fonti di riferimento scientifico riguardanti GW501516 anche se non si tratta di un supplemento alimentare ma di un composto per la ricerca tuttavia a causa del suo uso diffuso nel mondo del fitness e del body building molte persone fanno confusione.

1. Miner, J. N., & Hong, M.-H. (2007). Agonists of the peroxisome proliferator-activated receptor (PPAR-delta). US7223756B2. U.S. Patent and Trademark Office. Link
2. Liu, D., Wang, L., & Wang, Z. (2018). PPARδ agonist GW501516 inhibits PDGF-stimulated pulmonary arterial smooth muscle cell function related to pathological vascular remodeling. Biomedicine & Pharmacotherapy, 97, 458–467. Link
3. Sprecher, D. L., Massien, C., Pearce, G., Billin, A. N., Perlstein, I., Willson, T. M., Hassall, D. G., Ancellin, N., Patterson, S. D., Lobe, D. C., & Johnson, T. G. (2007). Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(2), 359–365. Link
4. Smith, R. V., Havens, A. M., & Nebert, D. W. (2017). The PPAR-δ agonist GW501516 prevents the development of osteoarthritis in mouse. Current Research